HomeSHAILY › Filing
🔔 Get instant alerts when SHAILY files quarterly results on BSE Start free trial →

Investor Presentation for quarter ended on June 30 2026

Filed: 08 Aug 2026, 19:00 IST Exchange: BSE Category: Financial Results — Investor Presentation
Investor Presentation - Q1FY27 - Revenue 280.7 Cr +14% y-y; EBITDA 83.3 Cr +18% y-y; EBITDA margin 29.7% (+120 bps); PAT 48.0 Cr +17% y-y - Healthcare segment revenue up 85% y-y, key growth driver; Consumer segment down 24% y-y - New projects confirmed in FMCG, LED lights, appliances, consumer electronics, automotive, and healthcare - RoCE improved to 39.0% and RoE to 28.2% on annualized basis in Q1FY27 - Debt to equity ratio improved to 0.2; fixed asset turnover increased to 1.9 - Domestic vs export revenue mix shifted due to growing healthcare business - MD and Board emphasize sustained growth with diversified client base and strong credit ratings
Source: Original filing PDF — view on exchange portal
⚡ You're reading this after the fact — subscribers got it instantly
ISA
Indian Stock Alerts BOT
🚨 SHAILY — Quarterly Results
Revenue: ₹2,35,800 Cr (+12% YoY)
PAT: ₹19,200 Cr (+17% YoY)
EBITDA margin: 16.8%
Board declared ₹10/share dividend. Jio adds 8M subs.
✓✓ 6:47 PM
🎧
Instant audio summaries2-min AI concall recap delivered with every earnings alert
📊
20-quarter financialsRevenue, PAT, EBITDA, margins — auto-extracted from filings
🔍
Forensic red-flag screenAudit, governance, accruals & RPT flags scored automatically
Instant Telegram alertsResults, board meetings, insider trades — within minutes

Add SHAILY to your watchlist — all of this, automated.

Sign in with Google
14-day Pro trial · No credit card · Cancel anytime

More on Shaily Engineering Plastics Limited

Important. The summary above is generated automatically from Shaily Engineering Plastics Limited's own public regulatory filing under SEBI LODR. Indian Stock Alerts is not a SEBI-registered Research Analyst or Investment Adviser. This page is informational, not investment advice, a recommendation to buy or sell any security, or any opinion about the company's business, governance or financial health. Always read the original filing before acting and consult a registered adviser for investment decisions.